Miami, FL, United States of America

Hermann Pelzer

This inventor holds 1 USPTO granted patent. Top assignee: Behring Diagnostics Gmbh. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hermann Pelzer. Retrieved from https://idiyas.com/inventor/hermann-pelzer-6mj66920

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hermann Pelzer: Innovator in Monoclonal Antibodies

Introduction

Hermann Pelzer is a notable inventor based in Miami, FL (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for diagnostics and therapeutic applications.

Latest Patents

Hermann Pelzer holds a patent for "Monoclonal antibodies against the plasmin-antiplasmin complex." This invention relates to monoclonal antibodies (MAbs) and fragments that exhibit a specific affinity for the plasmin-antiplasmin complex. Importantly, these antibodies display little to no affinity for the individual components of these complexes. The antibodies, antibody fragments, and antigens derived from this invention can serve as diagnostic aids, active substances, or carriers for active substances.

Career Highlights

Hermann Pelzer is associated with Behring Diagnostics GmbH, where he continues to advance research in the field of monoclonal antibodies. His innovative work has positioned him as a key figure in the biotechnology sector.

Collaborations

Hermann Pelzer collaborates with Johann Hock, contributing to the advancement of their shared research interests.

Conclusion

Hermann Pelzer's contributions to the field of monoclonal antibodies highlight his innovative spirit and dedication to advancing medical science. His work continues to impact diagnostics and therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…